Skip to content
Preprint · OA via OpenAlex

β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

Eliezer Masliah, Edward M. Rockenstein, Isaac Veinbergs, Yutaka Sagara, Margaret E. Mallory, Makoto Hashimoto, Lennart Mucke

Proceedings of the National Academy of Sciences · 2001 · ▲ 607 citations

Abstract

Alzheimer's disease and Parkinson's disease are associated with the cerebral accumulation of beta-amyloid and alpha-synuclein, respectively. Some patients have clinical and pathological features of both diseases, raising the possibility of overlapping pathogenetic pathways. We generated transgenic (tg) mice with neuronal expression of human beta-amyloid peptides, alpha-synuclein, or both. The functional and morphological alterations in doubly tg mice resembled the Lewy-body variant of Alzheimer's disease. These mice had severe deficits in learning and memory, developed motor deficits before alpha-synuclein singly tg mice, and showed prominent age-dependent degeneration of cholinergic neurons and presynaptic terminals. They also had more alpha-synuclein-immunoreactive neuronal inclusions than alpha-synuclein singly tg mice. Ultrastructurally, some of these inclusions were fibrillar in doubly tg mice, whereas all inclusions were amorphous in alpha-synuclein singly tg mice. beta-Amyloid peptides promoted aggregation of alpha-synuclein in a cell-free system and intraneuronal accumulation of alpha-synuclein in cell culture. beta-Amyloid peptides may contribute to the development of Lewy-body diseases by promoting the aggregation of alpha-synuclein and exacerbating alpha-synuclein-dependent neuronal pathologies. Therefore, treatments that block the production or accumulation of beta-amyloid peptides could benefit a broader spectrum of disorders than previously anticipated.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1073/pnas.211412398
Canonical
link ↗
Fetched
2026-10-20 MST

Cite this

APA
Masliah, E., Rockenstein, E.M., Veinbergs, I., Sagara, Y., Mallory, M.E., Hashimoto, M., &amp; Mucke, L. (2001). β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.211412398
Vancouver
Masliah E, Rockenstein EM, Veinbergs I, Sagara Y, Mallory ME, Hashimoto M, et al. β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proceedings of the National Academy of Sciences. 2001. doi:10.1073/pnas.211412398.
BibTeX
@unpublished{eliezer2001Amyloi, title = {β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease}, author = {Eliezer Masliah and Edward M. Rockenstein and Isaac Veinbergs and Yutaka Sagara and Margaret E. Mallory and Makoto Hashimoto and Lennart Mucke}, journal = {Proceedings of the National Academy of Sciences}, year = {2001}, doi = {10.1073/pnas.211412398}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings